Entity
  • NovAliX

    Created in 2002
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    300 14,565
  • Activities

  • Technologies

  • Entity types

  • Location

    16 Rue d'Ankara, 67000 Strasbourg, France

    Strasbourg

    France

  • Employees

    Scale: 201-500

    Estimated: 382

  • SIREN

    444361851
  • Engaged corporates

    29
    4 27
  • Added in Motherbase

    5 years, 4 months ago
Description
  • Value proposition

    NovAliX is a preclinical drug discovery-focused CRO

    NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com

    Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research

  • Original language

    NovAliX is a preclinical drug discovery-focused CRO

    NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com

  • NovAliX - Preclinical CRO. Drug discovery services

    NovAliX is a preclinical CRO providing drug discovery services. Highly proficient in both chemistry and biophysics with unique technologies

  • https://novalix.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Other

27 Apr 2023


SEMIA
SEMIA
Startup accelerator & VC, Business Consulting and Services
SEMIA
Startup accelerator & VC, Business Consulting and Services
Other

8 Apr 2023


SATT CONECTUS
SATT CONECTUS
Research, Research Services
SATT CONECTUS
Research, Research Services
Other

22 Oct 2023


Région Grand Est
Région Grand Est
National and local authorities, Government Administration
Région Grand Est
National and local authorities, Government Administration
Other

30 Sep 2022


BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

21 May 2019

21 Jun 2024



Direction Générale des Entreprises
Direction Générale des Entreprises
National and local authorities, Government Administration
Direction Générale des Entreprises
National and local authorities, Government Administration
Other

30 Sep 2022


Groupe Caisse des Dépôts
Groupe Caisse des Dépôts
Finance, Government Administration
Groupe Caisse des Dépôts
Finance, Government Administration
Other

30 Sep 2022


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

25 May 2021

30 Mar 2023



Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Not event

30 Nov 2022


Similar entities
Loading...
Loading...
Social network dynamics